These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22241017)
1. Visual outcome in Japanese patients with Acanthamoeba keratitis. Yamazoe K; Yamamoto Y; Shimazaki-Den S; Shimazaki J Eye (Lond); 2012 Apr; 26(4):517-22. PubMed ID: 22241017 [TBL] [Abstract][Full Text] [Related]
2. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. Robaei D; Carnt N; Minassian DC; Dart JK Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis. Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441 [TBL] [Abstract][Full Text] [Related]
5. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis. Carnt N; Robaei D; Watson SL; Minassian DC; Dart JK Ophthalmology; 2016 May; 123(5):984-90. PubMed ID: 26952591 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905 [TBL] [Abstract][Full Text] [Related]
12. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208 [TBL] [Abstract][Full Text] [Related]
14. Acanthamoeba keratitis: a parasite on the rise. Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320 [TBL] [Abstract][Full Text] [Related]
15. Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK. Hassan F; Bhatti A; Desai R; Barua A Cont Lens Anterior Eye; 2019 Oct; 42(5):506-511. PubMed ID: 31018907 [TBL] [Abstract][Full Text] [Related]
17. A 5-Year Review of Acanthamoeba Keratitis Related to Wearing Contact Lenses in Korea. Jo YJ; Jang SK; Lee J; Lee JS Eye Contact Lens; 2020 Jul; 46(4):223-227. PubMed ID: 32443003 [TBL] [Abstract][Full Text] [Related]
18. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179 [TBL] [Abstract][Full Text] [Related]
19. Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis. Ikeda Y; Miyazaki D; Yakura K; Kawaguchi A; Ishikura R; Inoue Y; Mito T; Shiraishi A; Ohashi Y; Higaki S; Itahashi M; Fukuda M; Shimomura Y; Yagita K Ophthalmology; 2012 Jun; 119(6):1111-9. PubMed ID: 22381810 [TBL] [Abstract][Full Text] [Related]
20. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. Bang S; Edell E; Eghrari AO; Gottsch JD Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]